David Domzalski Vyne Therapeutics Inc. (VYNE) insider trading activity

VYNE Quotes by TradingView

David Domzalski is PRESIDENT AND CEO of VYNE Therapeutics Inc.. Currently has a direct ownership of 416,208 shares of VYNE, which is worth approximately $153,996. The most recent transaction as insider was on Mar 17, 2022, when has been sold 312,302 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 416K
2.96% 3M change
12.57% 12M change
Total Value Held $153,996

David Domzalski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 17 2022
BUY
Grant, award, or other acquisition
-
312,302 Added 22.55%
1,072,935 Common Stock
Dec 31 2021
SELL
Payment of exercise price or tax liability
$7,025 $1.02 p/Share
6,887 Reduced 0.9%
760,633 Common Stock
Nov 30 2021
BUY
Grant, award, or other acquisition
$4,140 $0.88 p/Share
4,705 Added 0.61%
767,520 Common Stock
Sep 30 2021
SELL
Payment of exercise price or tax liability
$18,203 $1.39 p/Share
13,096 Reduced 1.69%
762,815 Common Stock
Sep 02 2021
BUY
Grant, award, or other acquisition
-
320,312 Added 29.22%
775,911 Common Stock
Jun 30 2021
SELL
Payment of exercise price or tax liability
$66,195 $3.51 p/Share
18,859 Reduced 3.97%
455,599 Common Stock
May 28 2021
BUY
Grant, award, or other acquisition
$3,162 $3.36 p/Share
941 Added 0.2%
474,458 Common Stock
Mar 31 2021
SELL
Payment of exercise price or tax liability
$43,201 $6.84 p/Share
6,316 Reduced 1.32%
473,517 Common Stock
Feb 22 2021
BUY
Grant, award, or other acquisition
-
153,750 Added 24.27%
479,833 Common Stock
Dec 31 2020
SELL
Payment of exercise price or tax liability
$15,256 $1.58 p/Share
9,656 Reduced 0.73%
1,304,334 Common Stock
Nov 30 2020
BUY
Grant, award, or other acquisition
$6,181 $1.45 p/Share
4,263 Added 0.32%
1,313,990 Common Stock
Sep 30 2020
SELL
Payment of exercise price or tax liability
$10,357 $1.66 p/Share
6,239 Reduced 0.47%
1,309,727 Common Stock
DD

David Domzalski

PRESIDENT AND CEO
Bridgewater, NJ

Track Institutional and Insider Activities on VYNE

Follow VYNE Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYNE shares.

Notify only if

Insider Trading

Get notified when an Vyne Therapeutics Inc. insider buys or sells VYNE shares.

Notify only if

News

Receive news related to VYNE Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VYNE